{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:59:32Z","timestamp":1792299572359,"version":"4.4.0"},"reference-count":206,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T00:00:00Z","timestamp":1689638400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.bbr.2023.114574","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T20:58:46Z","timestamp":1688763526000},"page":"114574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Gut-to-brain spreading of pathology in synucleinopathies: A focus on molecular signalling mediators"],"prefix":"10.1016","volume":"452","author":[{"given":"Verena","family":"Schmitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca Katharina","family":"Masanetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Weidenfeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara Savannah","family":"Ebbinghaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"S\u00fc\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan P.","family":"Rosshart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"von H\u00f6rsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"Zunke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0347-619X","authenticated-orcid":false,"given":"Wei","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2023.114574_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41531-021-00203-9","article-title":"Alpha-synuclein research: defining strategic moves in the battle against Parkinson's disease","volume":"7","author":"Oliveira","year":"2021","journal-title":"NPJ Park. Dis."},{"key":"10.1016\/j.bbr.2023.114574_bib2","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1007\/s12035-015-9205-3","article-title":"Oligodendroglia and Myelin in Neurodegenerative Diseases: More Than Just Bystanders?","volume":"53","author":"Ettle","year":"2016","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.bbr.2023.114574_bib3","first-page":"9","article-title":"Inflammation in parkinson's disease: mechanisms and therapeutic implications","author":"Pajares","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bbr.2023.114574_bib4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3389\/fncel.2015.00437","article-title":"Neuroinflammation in multiple system atrophy: response to and cause of alpha-synuclein aggregation","volume":"9","author":"Vieira","year":"2015","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.bbr.2023.114574_bib5","first-page":"S3","article-title":"The emerging evidence of the parkinson pandemic","volume":"8","author":"Dorsey","year":"2018","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.bbr.2023.114574_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.14108","article-title":"Parkinson disease","volume":"27","author":"Balestrino","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.bbr.2023.114574_bib7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2741\/S415","article-title":"Parkinson's disease: a review","volume":"6","author":"Beitz","year":"2014","journal-title":"Front Biosci."},{"key":"10.1016\/j.bbr.2023.114574_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","article-title":"Parkinson disease epidemiology, pathology, genetics, and pathophysiology","volume":"36","author":"Simon","year":"2020","journal-title":"Clin. Geriatr. Med"},{"key":"10.1016\/j.bbr.2023.114574_bib9","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/jnnp-2012-302500","article-title":"Incidence and prevalence of multiple system atrophy: a nationwide study in Iceland","volume":"84","author":"Bjornsdottir","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbr.2023.114574_bib10","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1212\/WNL.49.5.1284","article-title":"Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990","volume":"49","author":"Bower","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2023.114574_bib11","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(99)04137-9","article-title":"Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study","volume":"354","author":"Schrag","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.bbr.2023.114574_bib12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/B978-0-444-53491-0.00019-5","article-title":"Multiple system atrophy","volume":"117","author":"Wenning","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.bbr.2023.114574_bib13","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1007\/s00415-020-09881-6","article-title":"An update on MSA: premotor and non-motor features open a window of opportunities for early diagnosis and intervention","volume":"267","author":"Chelban","year":"2020","journal-title":"J. Neurol."},{"issue":"Suppl 1","key":"10.1016\/j.bbr.2023.114574_bib14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/jnc.13750","article-title":"Current and experimental treatments of Parkinson disease: A guide for neuroscientists","volume":"139","author":"Oertel","year":"2016","journal-title":"J. Neurochem"},{"key":"10.1016\/j.bbr.2023.114574_bib15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fncel.2016.00293","article-title":"Early degeneration of both dopaminergic and serotonergic axons - a common mechanism in parkinson's disease","volume":"10","author":"Grosch","year":"2016","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.bbr.2023.114574_bib16","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of parkinson disease: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.bbr.2023.114574_bib17","article-title":"Molecular communication between neuronal networks and intestinal epithelial cells in gut inflammation and parkinson's disease","volume":"8","author":"Drobny","year":"2021","journal-title":"Front Med ("},{"key":"10.1016\/j.bbr.2023.114574_bib18","first-page":"22","article-title":"The gut-brain axis in inflammatory bowel disease-current and future perspectives","author":"Gunther","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.bbr.2023.114574_bib19","article-title":"The Gut-brain axis and its relation to parkinson's disease: a review","volume":"13","author":"Klann","year":"2021","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.bbr.2023.114574_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.698172","article-title":"The microbiota-gut-brain axis in health and disease and its implications for translational research","volume":"15","author":"Schachtle","year":"2021","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.bbr.2023.114574_bib21","first-page":"2339","article-title":"Exploring the connection between the gut microbiome and parkinson's disease symptom progression and pathology: implications for supplementary treatment options","volume":"12","author":"Chan","year":"2022","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.bbr.2023.114574_bib22","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/mds.1203","article-title":"Gastric emptying time and gastric motility in patients with Parkinson's disease","volume":"16","author":"Hardoff","year":"2001","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbr.2023.114574_bib23","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1021\/acschemneuro.9b00607","article-title":"Association of intestinal disorders with parkinson's disease and alzheimer's disease: a systematic review and meta-analysis","volume":"11","author":"Fu","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bbr.2023.114574_bib24","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/mds.22841","article-title":"Real-time visualization of altered gastric motility by magnetic resonance imaging in patients with Parkinson's disease","volume":"25","author":"Unger","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbr.2023.114574_bib25","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00415-005-0815-y","article-title":"Gastric emptying after semi-solid food in multiple system atrophy and Parkinson disease","volume":"252","author":"Thomaides","year":"2005","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbr.2023.114574_bib26","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1007\/s00415-011-6372-7","article-title":"Is there delayed gastric emptying in patients with multiple system atrophy? An analysis using the (13)C-acetate breath test","volume":"259","author":"Tanaka","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbr.2023.114574_bib27","first-page":"12","article-title":"Constipation symptoms in multiple system atrophy using rome criteria and their impact on personalized medicine","author":"Mishima","year":"2022","journal-title":"J. Pers. Med"},{"key":"10.1016\/j.bbr.2023.114574_bib28","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s10286-005-0294-3","article-title":"Impaired circadian rhythm of gastric myoelectrical activity in patients with multiple system atrophy","volume":"15","author":"Suzuki","year":"2005","journal-title":"Clin. Auton. Res"},{"key":"10.1016\/j.bbr.2023.114574_bib29","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/mds.20165","article-title":"Colonic transit time, sphincter EMG, and rectoanal videomanometry in multiple system atrophy","volume":"19","author":"Sakakibara","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbr.2023.114574_bib30","first-page":"331","article-title":"The potential role of gut-derived inflammation in multiple system atrophy","volume":"7","author":"Engen","year":"2017","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.bbr.2023.114574_bib31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40478-015-0196-0","article-title":"Structural alterations of the intestinal epithelial barrier in Parkinson's disease","volume":"3","author":"Clairembault","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbr.2023.114574_bib32","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/mds.27326","article-title":"Stool immune profiles evince gastrointestinal inflammation in parkinson's disease","volume":"33","author":"Houser","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbr.2023.114574_bib33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.nbd.2012.09.007","article-title":"Colonic inflammation in Parkinson's disease","volume":"50","author":"Devos","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbr.2023.114574_bib34","article-title":"Risk of neurodegenerative diseases in patients with inflammatory bowel disease: a nationwide population-based cohort study","author":"Kim","year":"2021","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.bbr.2023.114574_bib35","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/jamaneurol.2017.0469","article-title":"International Parkinson's Disease Genomics Consortium, N.A.B.E.C.,United Kingdom Brain Expression Consortium, I. Genome-wide Pleiotropy Between Parkinson Disease and Autoimmune Diseases","volume":"74","author":"Witoelar","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bbr.2023.114574_bib36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","article-title":"Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology","volume":"396","author":"Braak","year":"2006","journal-title":"Neurosci. Lett."},{"issue":"Suppl 3","key":"10.1016\/j.bbr.2023.114574_bib37","article-title":"Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages)","volume":"249","author":"Braak","year":"2002","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbr.2023.114574_bib38","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","article-title":"Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen","volume":"110","author":"Braak","year":"2003","journal-title":"J. Neural Transm. (Vienna) ("},{"key":"10.1016\/j.bbr.2023.114574_bib39","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00401-009-0538-8","article-title":"Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction","volume":"117","author":"Beach","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbr.2023.114574_bib40","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.bbadis.2008.07.006","article-title":"A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders","volume":"1792","author":"Jellinger","year":"2009","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.bbr.2023.114574_bib41","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00401-008-0344-8","article-title":"The progression of pathology in longitudinally followed patients with Parkinson's disease","volume":"115","author":"Halliday","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbr.2023.114574_bib42","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00702-018-1898-9","article-title":"Is Braak staging valid for all types of Parkinson's disease?","volume":"126","author":"Jellinger","year":"2019","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.bbr.2023.114574_bib43","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2990.2007.00923.x","article-title":"The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of alpha-synuclein staging","volume":"34","author":"Kalaitzakis","year":"2008","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.bbr.2023.114574_bib44","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00401-008-0346-6","article-title":"Applicability of current staging\/categorization of alpha-synuclein pathology and their clinical relevance","volume":"115","author":"Parkkinen","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbr.2023.114574_bib45","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1002\/mds.28636","article-title":"Onset of skin, gut, and genitourinary prodromal parkinson's disease: a study of 1.5 million veterans","volume":"36","author":"Scott","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbr.2023.114574_bib46","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00401-014-1343-6","article-title":"Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats","volume":"128","author":"Holmqvist","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbr.2023.114574_bib47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13024-018-0257-5","article-title":"Inoculation of alpha-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve","volume":"13","author":"Uemura","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbr.2023.114574_bib48","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1093\/brain\/awaa096","article-title":"Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates","volume":"143","author":"Arotcarena","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.bbr.2023.114574_bib49","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13024-021-00439-2","article-title":"Parkinson mice show functional and molecular changes in the gut long before motoric disease onset","volume":"16","author":"Gries","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbr.2023.114574_bib50","first-page":"13","article-title":"Development and maintenance of the gut-associated lymphoid tissue (GALT): the roles of enteric bacteria and viruses","volume":"6","author":"Cebra","year":"1998","journal-title":"Dev. Immunol."},{"key":"10.1016\/j.bbr.2023.114574_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1651-2227.1994.tb13390.x","article-title":"Development of human intestinal and gastric enzymes","volume":"405","author":"Menard","year":"1994","journal-title":"Acta Paediatr. Suppl."},{"key":"10.1016\/j.bbr.2023.114574_bib52","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/MED.0000000000000707","article-title":"Gastrointestinal hormones and regulation of gastric emptying","volume":"29","author":"Mori","year":"2022","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.bbr.2023.114574_bib53","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1002\/jsfa.7601","article-title":"Human digestion--a processing perspective","volume":"96","author":"Boland","year":"2016","journal-title":"J. Sci. Food Agric."},{"key":"10.1016\/j.bbr.2023.114574_bib54","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13244-019-0719-5","article-title":"Imaging of cranial nerves: a pictorial overview","volume":"10","author":"Romano","year":"2019","journal-title":"Insights Imaging"},{"key":"10.1016\/j.bbr.2023.114574_bib55","doi-asserted-by":"crossref","DOI":"10.4110\/in.2021.21.e20","article-title":"Gut-brain connection: microbiome, gut barrier, and environmental sensors","volume":"21","author":"Gwak","year":"2021","journal-title":"Immune Netw."},{"key":"10.1016\/j.bbr.2023.114574_bib56","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40478-015-0198-y","article-title":"Neuron-to-neuron alpha-synuclein propagation in vivo is independent of neuronal injury","volume":"3","author":"Ulusoy","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbr.2023.114574_bib57","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/emmm.201302475","article-title":"Caudo-rostral brain spreading of alpha-synuclein through vagal connections","volume":"5","author":"Ulusoy","year":"2013","journal-title":"EMBO Mol. Med"},{"key":"10.1016\/j.bbr.2023.114574_bib58","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","article-title":"Transneuronal propagation of pathologic alpha-synuclein from the gut to the brain models parkinson's disease","volume":"103","author":"Kim","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.bbr.2023.114574_bib59","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ana.24448","article-title":"Vagotomy and subsequent risk of Parkinson's disease","volume":"78","author":"Svensson","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbr.2023.114574_bib60","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1212\/WNL.0000000000003961","article-title":"Vagotomy and Parkinson disease: A Swedish register-based matched-cohort study","volume":"88","author":"Liu","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2023.114574_bib61","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40478-015-0236-9","article-title":"Distribution of alpha-synuclein in the spinal cord and dorsal root ganglia in an autopsy cohort of elderly persons","volume":"3","author":"Sumikura","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbr.2023.114574_bib62","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00401-019-02040-w","article-title":"Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats","volume":"138","author":"Van Den Berge","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbr.2023.114574_bib63","first-page":"S281","article-title":"Brain-first versus gut-first parkinson's disease: a hypothesis","volume":"9","author":"Borghammer","year":"2019","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.bbr.2023.114574_bib64","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1096\/fj.03-1449com","article-title":"Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson\u2019s disease","volume":"20","author":"El-Agnaf","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.bbr.2023.114574_bib65","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00401-014-1314-y","article-title":"Plasma exosomal alpha-synuclein is likely CNS-derived and increased in Parkinson's disease","volume":"128","author":"Shi","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbr.2023.114574_bib66","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/jnnp-2019-322588","article-title":"Serum neuronal exosomes predict and differentiate Parkinson's disease from atypical parkinsonism","volume":"91","author":"Jiang","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbr.2023.114574_bib67","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awac115","article-title":"Detection of neuron-derived pathological alpha-synuclein in blood","author":"Kluge","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.bbr.2023.114574_bib68","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12974-022-02413-1","article-title":"alpha-Synuclein-containing erythrocytic extracellular vesicles: essential contributors to hyperactivation of monocytes in Parkinson's disease","volume":"19","author":"Liu","year":"2022","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.bbr.2023.114574_bib69","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbr.2023.114574_bib70","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1093\/brain\/awt192","article-title":"Disease duration and the integrity of the nigrostriatal system in Parkinson's disease","volume":"136","author":"Kordower","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.bbr.2023.114574_bib71","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm1746","article-title":"Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation","volume":"14","author":"Li","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.bbr.2023.114574_bib72","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1073\/pnas.1605245113","article-title":"Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain","volume":"113","author":"Li","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bbr.2023.114574_bib73","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1002\/mds.28628","article-title":"Recent advances in the development of stem-cell-derived dopaminergic neuronal transplant therapies for parkinson's disease","volume":"36","author":"Barbuti","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbr.2023.114574_bib74","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/B978-0-444-59575-1.00010-7","article-title":"Neuropathology in transplants in Parkinson's disease: implications for disease pathogenesis and the future of cell therapy","volume":"200","author":"Brundin","year":"2012","journal-title":"Prog. Brain Res"},{"key":"10.1016\/j.bbr.2023.114574_bib75","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0304-3940(00)01153-8","article-title":"Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson\u2019s disease and normal subjects","volume":"287","author":"Borghi","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bbr.2023.114574_bib76","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.neulet.2012.11.004","article-title":"Total CSF alpha-synuclein is lower in de novo Parkinson patients than in healthy subjects","volume":"532","author":"Mollenhauer","year":"2013","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bbr.2023.114574_bib77","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/15548627.2017.1395992","article-title":"Autophagy inhibition promotes SNCA\/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype","volume":"14","author":"Minakaki","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.bbr.2023.114574_bib78","doi-asserted-by":"crossref","DOI":"10.4161\/auto.36436","article-title":"Autophagy modulates SNCA\/alpha-synuclein release, thereby generating a hostile microenvironment","author":"Poehler","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.bbr.2023.114574_bib79","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.bbrc.2016.09.109","article-title":"Alpha-synuclein activates BV2 microglia dependent on its aggregation state","volume":"479","author":"Hoffmann","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bbr.2023.114574_bib80","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41598-018-35811-8","article-title":"Extracellular aggregated alpha synuclein primarily triggers lysosomal dysfunction in neural cells prevented by trehalose","volume":"9","author":"Hoffmann","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbr.2023.114574_bib81","first-page":"10","article-title":"Alpha-synuclein: mechanisms of release and pathology progression in synucleinopathies","author":"Bras","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bbr.2023.114574_bib82","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fnmol.2019.00107","article-title":"Spreading of alpha-synuclein and tau: a systematic comparison of the mechanisms involved","volume":"12","author":"Vasili","year":"2019","journal-title":"Front Mol. Neurosci."},{"key":"10.1016\/j.bbr.2023.114574_bib83","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00687767","article-title":"Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses","volume":"76","author":"Wakabayashi","year":"1988","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbr.2023.114574_bib84","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/mds.25988","article-title":"In vivo gastric detection of alpha-synuclein inclusions in Parkinson's disease","volume":"30","author":"Sanchez-Ferro","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbr.2023.114574_bib85","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/mds.23838","article-title":"Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease","volume":"27","author":"Shannon","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbr.2023.114574_bib86","first-page":"2","article-title":"alpha-Synuclein in gut endocrine cells and its implications for Parkinson\u2019s disease","author":"Chandra","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbr.2023.114574_bib87","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41531-023-00458-4","article-title":"Patients with isolated REM-sleep behavior disorder have elevated levels of alpha-synuclein aggregates in stool","volume":"9","author":"Schaffrath","year":"2023","journal-title":"NPJ Park. Dis."},{"key":"10.1016\/j.bbr.2023.114574_bib88","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00401-021-02381-5","article-title":"Immunisation with UB-312 in the Thy1SNCA mouse prevents motor performance deficits and oligomeric alpha-synuclein accumulation in the brain and gut","volume":"143","author":"Nimmo","year":"2022","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbr.2023.114574_bib89","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.expneurol.2009.07.025","article-title":"Alpha-synuclein immunopositive aggregates in the myenteric plexus of the aging Fischer 344 rat","volume":"220","author":"Phillips","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbr.2023.114574_bib90","doi-asserted-by":"crossref","first-page":"e621","DOI":"10.1111\/nmo.12176","article-title":"Alpha-synuclein expression patterns in the colonic submucosal plexus of the aging Fischer 344 rat: implications for biopsies in aging and neurodegenerative disorders?","volume":"25","author":"Phillips","year":"2013","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.bbr.2023.114574_bib91","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.nbd.2018.01.008","article-title":"Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology","volume":"112","author":"Manfredsson","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbr.2023.114574_bib92","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41593-020-0589-7","article-title":"Gut-seeded alpha-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice","volume":"23","author":"Challis","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbr.2023.114574_bib93","doi-asserted-by":"crossref","first-page":"8787","DOI":"10.3748\/wjg.v21.i29.8787","article-title":"Role of the normal gut microbiota","volume":"21","author":"Jandhyala","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbr.2023.114574_bib94","first-page":"81","article-title":"The First microbial colonizers of the human gut: composition, activities, and health implications of the infant gut microbiota","author":"Milani","year":"2017","journal-title":"Microbiol Mol. Biol. Rev."},{"key":"10.1016\/j.bbr.2023.114574_bib95","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1042\/BCJ20160510","article-title":"Introduction to the human gut microbiota","volume":"474","author":"Thursby","year":"2017","journal-title":"Biochem J."},{"key":"10.1016\/j.bbr.2023.114574_bib96","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","article-title":"The role of short-chain fatty acids in microbiota-gut-brain communication","volume":"16","author":"Dalile","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbr.2023.114574_bib97","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/jvim.14875","article-title":"The gastrointestinal microbiome: a review","volume":"32","author":"Barko","year":"2018","journal-title":"J. Vet. Intern Med"},{"key":"10.1016\/j.bbr.2023.114574_bib98","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1152\/physrev.00045.2009","article-title":"Gut microbiota in health and disease","volume":"90","author":"Sekirov","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbr.2023.114574_bib99","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3389\/fnins.2019.01102","article-title":"Alterations of the gut microbiota in multiple system atrophy patients","volume":"13","author":"Wan","year":"2019","journal-title":"Front Neurosci."},{"key":"10.1016\/j.bbr.2023.114574_bib100","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3389\/fneur.2020.01041","article-title":"Changes in gastrointestinal microbiome composition in PD: a pivotal role of covariates","volume":"11","author":"Cosma-Grigorov","year":"2020","journal-title":"Front Neurol."},{"key":"10.1016\/j.bbr.2023.114574_bib101","first-page":"5","article-title":"Gut microbiota and metabolome alterations associated with parkinson's disease","author":"Vascellari","year":"2020","journal-title":"mSystems"},{"key":"10.1016\/j.bbr.2023.114574_bib102","first-page":"11","article-title":"Gut microbiota dysbiosis is associated with elevated bile acids in parkinson's disease","author":"Li","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.bbr.2023.114574_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.756951","article-title":"Changes in the gut microbiome and predicted functional metabolic effects in an australian parkinson's disease cohort","volume":"15","author":"Kenna","year":"2021","journal-title":"Front Neurosci."},{"key":"10.1016\/j.bbr.2023.114574_bib104","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/mds.26942","article-title":"Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome","volume":"32","author":"Hill-Burns","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbr.2023.114574_bib105","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/mds.28052","article-title":"Microbiota composition and metabolism are associated with gut function in parkinson's disease","volume":"35","author":"Cirstea","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbr.2023.114574_bib106","doi-asserted-by":"crossref","first-page":"e848","DOI":"10.1212\/WNL.0000000000013225","article-title":"Association of fecal and plasma levels of short-chain fatty acids with gut microbiota and clinical severity in patients with parkinson disease","volume":"98","author":"Chen","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2023.114574_bib107","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/mds.27581","article-title":"Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism","volume":"34","author":"Barichella","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbr.2023.114574_bib108","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13024-021-00427-6","article-title":"Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease","volume":"16","author":"Aho","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbr.2023.114574_bib109","first-page":"185","article-title":"A pilot microbiota study in parkinson's disease patients versus control subjects, and effects of FTY720 and FTY720-Mitoxy therapies in parkinsonian and multiple system atrophy mouse models","volume":"10","author":"Vidal-Martinez","year":"2020","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.bbr.2023.114574_bib110","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of parkinson's disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.bbr.2023.114574_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2021.106791","article-title":"Fecal microbiota transplant as a potential treatment for Parkinson's disease - A case series","volume":"207","author":"Segal","year":"2021","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.bbr.2023.114574_bib112","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbi.2018.02.005","article-title":"Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4\/TNF-alpha signaling pathway","volume":"70","author":"Sun","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbr.2023.114574_bib113","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1007\/s11064-021-03411-0","article-title":"Fecal microbiota transplantation exerts a protective role in MPTP-induced parkinson's disease via the TLR4\/PI3K\/AKT\/NF-kappaB pathway stimulated by alpha-synuclein","volume":"46","author":"Zhong","year":"2021","journal-title":"Neurochem Res"},{"key":"10.1016\/j.bbr.2023.114574_bib114","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s40168-021-01107-9","article-title":"Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis","volume":"9","author":"Zhao","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/j.bbr.2023.114574_bib115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev.micro.60.080805.142106","article-title":"Curli biogenesis and function","volume":"60","author":"Barnhart","year":"2006","journal-title":"Annu Rev. Microbiol"},{"key":"10.1016\/j.bbr.2023.114574_bib116","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3233\/JAD-220106","article-title":"Bacterial amyloid curli associated gut epithelial neuroendocrine activation predominantly observed in alzheimer's disease mice with central amyloid-beta pathology","volume":"88","author":"Das","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbr.2023.114574_bib117","doi-asserted-by":"crossref","first-page":"34477","DOI":"10.1038\/srep34477","article-title":"Exposure to the functional bacterial amyloid protein curli enhances alpha-synuclein aggregation in aged fischer 344 rats and Caenorhabditis elegans","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbr.2023.114574_bib118","first-page":"9","article-title":"A gut bacterial amyloid promotes alpha-synuclein aggregation and motor impairment in mice","author":"Sampson","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.bbr.2023.114574_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102088","article-title":"Mechanistic insights into accelerated alpha-synuclein aggregation mediated by human microbiome-associated functional amyloids","volume":"298","author":"Bhoite","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2023.114574_bib120","first-page":"118","article-title":"Genome-wide screen identifies curli amyloid fibril as a bacterial component promoting host neurodegeneration","author":"Wang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbr.2023.114574_bib121","first-page":"23","article-title":"Antibodies against HSV-1 and curli show the highest correlation in parkinson's disease patients in comparison to healthy controls","author":"Jasemi","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.bbr.2023.114574_bib122","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.638867","article-title":"Microbiome or infections: amyloid-containing biofilms as a trigger for complex human diseases","volume":"12","author":"Miller","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.bbr.2023.114574_bib123","first-page":"22","article-title":"The bacterial amyloids phenol soluble modulins from staphylococcus aureus catalyze alpha-synuclein aggregation","author":"Haikal","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.bbr.2023.114574_bib124","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.chembiol.2021.03.013","article-title":"Inhibition of staphylococcus aureus biofilm-forming functional amyloid by molecular tweezers","volume":"28","author":"Malishev","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.bbr.2023.114574_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101695","article-title":"Identification of a quorum sensing-dependent communication pathway mediating bacteria-gut-brain cross talk","volume":"23","author":"Uhlig","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.bbr.2023.114574_bib126","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1017\/S0029665120006916","article-title":"SCFA: mechanisms and functional importance in the gut","volume":"80","author":"Martin-Gallausiaux","year":"2021","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.bbr.2023.114574_bib127","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1079\/BJN19870073","article-title":"Stimulatory effect of short-chain fatty acids on epithelial cell proliferation in the rat intestine: a possible explanation for trophic effects of fermentable fibre, gut microbes and luminal trophic factors","volume":"58","author":"Sakata","year":"1987","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.bbr.2023.114574_bib128","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1053\/j.gastro.2010.01.053","article-title":"Short-chain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats","volume":"138","author":"Soret","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbr.2023.114574_bib129","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1365-2982.2006.00853.x","article-title":"The relationship between the effects of short-chain fatty acids on intestinal motility in vitro and GPR43 receptor activation","volume":"19","author":"Dass","year":"2007","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.bbr.2023.114574_bib130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.anaerobe.2015.01.005","article-title":"Gut microbial and short-chain fatty acid profiles in adults with chronic constipation before and after treatment with lubiprostone","volume":"33","author":"Kang","year":"2015","journal-title":"Anaerobe"},{"key":"10.1016\/j.bbr.2023.114574_bib131","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/codi.13314","article-title":"Function and clinical implications of short-chain fatty acids in patients with mixed refractory constipation","volume":"18","author":"Shi","year":"2016","journal-title":"Colorectal Dis."},{"key":"10.1016\/j.bbr.2023.114574_bib132","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1038\/s41467-020-18262-6","article-title":"Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity","volume":"11","author":"Yang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbr.2023.114574_bib133","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1038\/s41467-018-05901-2","article-title":"Microbiota-derived short-chain fatty acids promote Th1 cell IL-10 production to maintain intestinal homeostasis","volume":"9","author":"Sun","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbr.2023.114574_bib134","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/CIRCULATIONAHA.118.036652","article-title":"Short-chain fatty acid propionate protects from hypertensive cardiovascular damage","volume":"139","author":"Bartolomaeus","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.bbr.2023.114574_bib135","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.3748\/wjg.v13.i20.2826","article-title":"Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease","volume":"13","author":"Tedelind","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbr.2023.114574_bib136","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.3748\/wjg.15.5549","article-title":"Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E(2) and cytokines","volume":"15","author":"Cox","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbr.2023.114574_bib137","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1126\/science.aao5774","article-title":"Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes","volume":"359","author":"Zhao","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.bbr.2023.114574_bib138","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/dc20-2257","article-title":"Metformin affects gut microbiome composition and function and circulating short-chain fatty acids: a randomized trial","volume":"44","author":"Mueller","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbr.2023.114574_bib139","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jnutbio.2018.11.003","article-title":"Impact of dietary fiber supplementation on modulating microbiota-host-metabolic axes in obesity","volume":"64","author":"Mayengbam","year":"2019","journal-title":"J. Nutr. Biochem"},{"key":"10.1016\/j.bbr.2023.114574_bib140","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1042\/CS20200128","article-title":"Short-chain fatty acid, acylation and cardiovascular diseases","volume":"134","author":"Chen","year":"2020","journal-title":"Clin. Sci. (Lond. ) ("},{"key":"10.1016\/j.bbr.2023.114574_bib141","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12876-021-01613-y","article-title":"Short chain fatty acids and colon motility in a mouse model of irritable bowel syndrome","volume":"21","author":"Shaidullov","year":"2021","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.bbr.2023.114574_bib142","article-title":"Alterations in fecal short-chain fatty acids in patients with irritable bowel syndrome: A systematic review and meta-analysis","volume":"98","author":"Sun","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.bbr.2023.114574_bib143","doi-asserted-by":"crossref","first-page":"263ra158","DOI":"10.1126\/scitranslmed.3009759","article-title":"The gut microbiota influences blood-brain barrier permeability in mice","volume":"6","author":"Braniste","year":"2014","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.bbr.2023.114574_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105648","article-title":"Microbial-derived metabolites induce actin cytoskeletal rearrangement and protect blood-brain barrier function","volume":"25","author":"Knox","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.bbr.2023.114574_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2020.103493","article-title":"Short-chain fatty acids (SCFAs) alone or in combination regulate select immune functions of microglia-like cells","volume":"105","author":"Wenzel","year":"2020","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.bbr.2023.114574_bib146","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/sj.bjp.0705682","article-title":"Regulation of microglial inflammatory response by sodium butyrate and short-chain fatty acids","volume":"141","author":"Huuskonen","year":"2004","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.bbr.2023.114574_bib147","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fendo.2020.00025","article-title":"The role of short-chain fatty acids from gut microbiota in gut-brain communication","volume":"11","author":"Silva","year":"2020","journal-title":"Front Endocrinol."},{"key":"10.1016\/j.bbr.2023.114574_bib148","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","article-title":"Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls","volume":"32","author":"Unger","year":"2016","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.bbr.2023.114574_bib149","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.gpb.2021.08.009","article-title":"Effects of resistant starch on symptoms, fecal markers, and gut microbiota in parkinson's disease - The RESISTA-PD Trial","volume":"20","author":"Becker","year":"2022","journal-title":"Genom. Proteom. Bioinforma."},{"key":"10.1016\/j.bbr.2023.114574_bib150","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/mds.29063","article-title":"Parkinson's disease is associated with impaired gut-blood barrier for short-chain fatty acids","volume":"37","author":"Yang","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbr.2023.114574_bib151","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/mds.28016","article-title":"Plasma short-chain fatty acids in patients with parkinson's disease","volume":"35","author":"Shin","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbr.2023.114574_bib152","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12883-021-02544-7","article-title":"Serum short-chain fatty acids and its correlation with motor and non-motor symptoms in Parkinson's disease patients","volume":"22","author":"Wu","year":"2022","journal-title":"BMC Neurol."},{"key":"10.1016\/j.bbr.2023.114574_bib153","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jns.2017.08.3235","article-title":"Sodium butyrate exerts protective effect against Parkinson's disease in mice via stimulation of glucagon like peptide-1","volume":"381","author":"Liu","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbr.2023.114574_bib154","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1007\/s11064-020-03074-3","article-title":"Sodium butyrate exacerbates parkinson's disease by aggravating neuroinflammation and colonic inflammation in MPTP-induced mice model","volume":"45","author":"Qiao","year":"2020","journal-title":"Neurochem Res"},{"key":"10.1016\/j.bbr.2023.114574_bib155","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s13311-017-0585-0","article-title":"Anxiety, depression, and the microbiome: a role for gut peptides","volume":"15","author":"Lach","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bbr.2023.114574_bib156","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12964-020-00569-y","article-title":"The role of Neurotensin and its receptors in non-gastrointestinal cancers: a review","volume":"18","author":"Nikolaou","year":"2020","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bbr.2023.114574_bib157","first-page":"17","article-title":"The crosstalk between autonomic nervous system and blood vessels","volume":"10","author":"Sheng","year":"2018","journal-title":"Int J. Physiol. Pathophysiol. Pharm."},{"key":"10.1016\/j.bbr.2023.114574_bib158","first-page":"8","article-title":"Neuroimmune interactions in the gut and their significance for intestinal immunity","author":"Brinkman","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bbr.2023.114574_bib159","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/jnc.13378","article-title":"Proteolytic degradation of neuropeptide Y (NPY) from head to toe: Identification of novel NPY-cleaving peptidases and potential drug interactions in CNS and Periphery","volume":"135","author":"Wagner","year":"2015","journal-title":"J. Neurochem"},{"key":"10.1016\/j.bbr.2023.114574_bib160","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/mds.27095","article-title":"Assessments of plasma ghrelin levels in the early stages of parkinson's disease","volume":"32","author":"Song","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbr.2023.114574_bib161","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF02260903","article-title":"Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson's disease, multiple system atrophy and dementia of the Alzheimer type","volume":"4","author":"Martignoni","year":"1992","journal-title":"J. Neural Transm. Park Dis. Dement Sect."},{"key":"10.1016\/j.bbr.2023.114574_bib162","article-title":"Acylated ghrelin is protective against 6-OHDA-induced neurotoxicity by regulating autophagic flux","volume":"11","author":"He","year":"2020","journal-title":"Front Pharm."},{"key":"10.1016\/j.bbr.2023.114574_bib163","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.147023","article-title":"Ghrelin protects dopaminergic neurons against MPTP neurotoxicity through promoting autophagy and inhibiting endoplasmic reticulum mediated apoptosis","volume":"1746","author":"Wang","year":"2020","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2023.114574_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2021.102134","article-title":"Ghrelin protects against rotenone-induced cytotoxicity: Involvement of mitophagy and the AMPK\/SIRT1\/PGC1alpha pathway","volume":"87","author":"Wang","year":"2021","journal-title":"Neuropeptides"},{"key":"10.1016\/j.bbr.2023.114574_bib165","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/s41586-021-04359-5","article-title":"Sensory representation and detection mechanisms of gut osmolality change","volume":"602","author":"Ichiki","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2023.114574_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2020.129626","article-title":"TAT-tagging of VIP exerts positive allosteric modulation of the PAC1 receptor and enhances VIP neuroprotective effect in the MPTP mouse model of Parkinson's disease","volume":"1864","author":"Yu","year":"2020","journal-title":"Biochim Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.bbr.2023.114574_bib167","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/jnnp.70.6.784","article-title":"Increased plasma neurotensin concentrations in patients with Parkinson's disease","volume":"70","author":"Schimpff","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbr.2023.114574_bib168","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s12031-018-1171-6","article-title":"Preventive Effect of Two New Neurotensin Analogues on Parkinson's Disease Rat Model","volume":"66","author":"Lazarova","year":"2018","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.bbr.2023.114574_bib169","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fnint.2019.00013","article-title":"Multiple beneficial effects of ghrelin agonist, HM01 on homeostasis alterations in 6-hydroxydopamine model of parkinson's disease in male rats","volume":"13","author":"Minalyan","year":"2019","journal-title":"Front Integr. Neurosci."},{"issue":"Suppl 1","key":"10.1016\/j.bbr.2023.114574_bib170","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.5604\/01.3001.0010.5493","article-title":"Bile acid physiology","volume":"16","author":"Di Ciaula","year":"2017","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.bbr.2023.114574_bib171","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism","volume":"24","author":"Wahlstrom","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbr.2023.114574_bib172","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1210\/en.2015-1321","article-title":"Bile acids trigger GLP-1 release predominantly by accessing basolaterally located G protein-coupled bile acid receptors","volume":"156","author":"Brighton","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbr.2023.114574_bib173","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.897867","article-title":"Distinct bile acid signature in parkinson's disease with mild cognitive impairment","volume":"13","author":"Nie","year":"2022","journal-title":"Front Neurol."},{"key":"10.1016\/j.bbr.2023.114574_bib174","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s12035-012-8295-4","article-title":"Tauroursodeoxycholic acid prevents MPTP-induced dopaminergic cell death in a mouse model of Parkinson's disease","volume":"46","author":"Castro-Caldas","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbr.2023.114574_bib175","doi-asserted-by":"crossref","first-page":"9139","DOI":"10.1007\/s12035-018-1062-4","article-title":"Tauroursodeoxycholic acid improves motor symptoms in a mouse model of parkinson's disease","volume":"55","author":"Rosa","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbr.2023.114574_bib176","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1080\/1028415X.2020.1859729","article-title":"Tauroursodeoxycholic acid (TUDCA) is neuroprotective in a chronic mouse model of Parkinson's disease","volume":"25","author":"Cuevas","year":"2022","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.bbr.2023.114574_bib177","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.829525","article-title":"The emerging role of bile acids in the pathogenesis of inflammatory bowel disease","volume":"13","author":"Thomas","year":"2022","journal-title":"Front Immunol."},{"issue":"Suppl 1","key":"10.1016\/j.bbr.2023.114574_bib178","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.2119\/molmed.2015.00087","article-title":"High mobility group box protein 1 (HMGB1): the prototypical endogenous danger molecule","volume":"21","author":"Yang","year":"2015","journal-title":"Mol. Med"},{"key":"10.1016\/j.bbr.2023.114574_bib179","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajpath.2021.09.006","article-title":"Chronic intestinal inflammation suppresses brain activity by inducing neuroinflammation in mice","volume":"192","author":"Mitchell","year":"2022","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbr.2023.114574_bib180","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/gutjnl-2018-316844","article-title":"Role of TLR4 in the gut-brain axis in Parkinson's disease: a translational study from men to mice","volume":"68","author":"Perez-Pardo","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.bbr.2023.114574_bib181","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/bs.acc.2018.07.005","article-title":"Fecal Calprotectin","volume":"87","author":"Ayling","year":"2018","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/j.bbr.2023.114574_bib182","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072138","article-title":"S100A8 and S100A9 induce cytokine expression and regulate the NLRP3 inflammasome via ROS-dependent activation of NF-kappaB(1.)","volume":"8","author":"Simard","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2023.114574_bib183","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cca.2006.08.018","article-title":"Intrinsic function of S100A8\/A9 complex as an anti-inflammatory protein in liver injury induced by lipopolysaccharide in rats","volume":"376","author":"Ikemoto","year":"2007","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbr.2023.114574_bib184","first-page":"19","article-title":"Calcium-Binding Proteins S100A8 and S100A9: Investigation of Their Immune Regulatory Effect in Myeloid Cells","author":"Yang","year":"2018","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.bbr.2023.114574_bib185","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1515\/cclm-2018-1063","article-title":"Faecal calprotectin in inflammatory bowel diseases: a review focused on meta-analyses and routine usage limitations","volume":"57","author":"Laserna-Mendieta","year":"2019","journal-title":"Clin. Chem. Lab Med"},{"key":"10.1016\/j.bbr.2023.114574_bib186","doi-asserted-by":"crossref","first-page":"106","DOI":"10.14802\/jmd.21085","article-title":"Fecal Calprotectin in Parkinson's Disease and Multiple System Atrophy","volume":"15","author":"Hor","year":"2022","journal-title":"J. Mov. Disord."},{"key":"10.1016\/j.bbr.2023.114574_bib187","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.689723","article-title":"Serum and Fecal Markers of Intestinal Inflammation and Intestinal Barrier Permeability Are Elevated in Parkinson's Disease","volume":"15","author":"Dumitrescu","year":"2021","journal-title":"Front Neurosci."},{"key":"10.1016\/j.bbr.2023.114574_bib188","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3389\/fnins.2019.00992","article-title":"Fecal Calprotectin as a Marker of the Gut Immune System Activation Is Elevated in Parkinson's Disease","volume":"13","author":"Mulak","year":"2019","journal-title":"Front Neurosci."},{"key":"10.1016\/j.bbr.2023.114574_bib189","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.parkreldis.2018.02.022","article-title":"Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson's disease","volume":"50","author":"Schwiertz","year":"2018","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.bbr.2023.114574_bib190","first-page":"10","article-title":"Cell Biology of Tight Junction Barrier Regulation and Mucosal Disease","author":"Buckley","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bbr.2023.114574_bib191","doi-asserted-by":"crossref","unstructured":"Sturgeon, C.,Fasano, A. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers (2016) 4, e1251384. https:\/\/doi.org\/10.1080\/21688370.2016.1251384.","DOI":"10.1080\/21688370.2016.1251384"},{"key":"10.1016\/j.bbr.2023.114574_bib192","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1038\/s41467-020-15831-7","article-title":"Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis","volume":"11","author":"Tajik","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbr.2023.114574_bib193","doi-asserted-by":"crossref","first-page":"a009316","DOI":"10.1101\/cshperspect.a009316","article-title":"A guide to neurotoxic animal models of Parkinson's disease","volume":"1","author":"Tieu","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"10.1016\/j.bbr.2023.114574_bib194","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105599","article-title":"Animal models of brain-first and body-first Parkinson's disease","volume":"163","author":"Van Den Berge","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbr.2023.114574_bib195","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/jnr.10231","article-title":"Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters","volume":"68","author":"Rockenstein","year":"2002","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.bbr.2023.114574_bib196","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s13311-012-0104-2","article-title":"A progressive mouse model of Parkinson's disease: the Thy1-aSyn (\"Line 61\") mice","volume":"9","author":"Chesselet","year":"2012","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bbr.2023.114574_bib197","doi-asserted-by":"crossref","first-page":"e425","DOI":"10.1111\/j.1365-2982.2012.01974.x","article-title":"Mice overexpressing wild-type human alpha-synuclein display alterations in colonic myenteric ganglia and defecation","volume":"24","author":"Wang","year":"2012","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.bbr.2023.114574_bib198","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S1474-4422(11)70227-7","article-title":"Modelling of Parkinson's disease in mice","volume":"10","author":"Chesselet","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbr.2023.114574_bib199","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/WNR.0b013e3282ffda5e","article-title":"Abnormal colonic motility in mice overexpressing human wild-type alpha-synuclein","volume":"19","author":"Wang","year":"2008","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbr.2023.114574_bib200","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/s41467-020-15119-w","article-title":"Microglia clear neuron-released alpha-synuclein via selective autophagy and prevent neurodegeneration","volume":"11","author":"Choi","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbr.2023.114574_bib201","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1093\/brain\/awab061","article-title":"Ageing promotes pathological alpha-synuclein propagation and autonomic dysfunction in wild-type rats","volume":"144","author":"Van Den Berge","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.bbr.2023.114574_bib202","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1248\/bpb.34.92","article-title":"Parkinsonian rotenone mouse model: reevaluation of long-term administration of rotenone in C57BL\/6 mice","volume":"34","author":"Inden","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bbr.2023.114574_bib203","doi-asserted-by":"crossref","first-page":"1866974","DOI":"10.1080\/19490976.2020.1866974","article-title":"Role of gut microbiota in regulating gastrointestinal dysfunction and motor symptoms in a mouse model of Parkinson's disease","volume":"13","author":"Bhattarai","year":"2021","journal-title":"Gut Microbes"},{"key":"10.1016\/j.bbr.2023.114574_bib204","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s40478-021-01240-4","article-title":"Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology","volume":"9","author":"Houser","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbr.2023.114574_bib205","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1053\/j.gastro.2007.08.037","article-title":"Aging gastropathy-novel mechanisms: hypoxia, up-regulation of multifunctional phosphatase PTEN, and proapoptotic factors","volume":"133","author":"Tarnawski","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbr.2023.114574_bib206","first-page":"131","article-title":"Neurodegenerative disorders and gut-brain interactions","author":"Singh","year":"2021","journal-title":"J. Clin. Invest"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432823002929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432823002929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:46:57Z","timestamp":1759067217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432823002929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":206,"alternative-id":["S0166432823002929"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2023.114574","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut-to-brain spreading of pathology in synucleinopathies: A focus on molecular signalling mediators","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2023.114574","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114574"}}